Hypothesis
Transient elevation of NAD+ levels combined with a short‑acting lamin A/C modulator will restore nucleocytoplasmic transport efficiency in iPSC‑derived neurons without erasing the age‑related molecular signatures that direct conversion preserves, thereby improving functional maturation while retaining disease‑relevant phenotypes.
Rationale
Directly converted induced neurons retain donor‑age hallmarks such as nucleocytoplasmic defects, which make them superior for modeling late‑onset pathology [4]. However, these cells often show immature electrophysiology and poor survival, limiting scalability [3]. iPSC‑derived neurons, although scalable, lose many age‑related marks during full reprogramming, which can blunt disease phenotypes [4]. Recent work shows that NAD+ depletion exacerbates lamin A/C‑dependent nuclear envelope stiffness and impairs transport of RNA‑binding proteins implicated in ALS and FTLD [5]. Conversely, boosting NAD+ with precursors like nicotinamide riboside improves mitochondrial function and reduces nuclear stress [1], while transient inhibition of lamin A/C farnesylation (e.g., with a low‑dose FTase inhibitor) increases nuclear envelope pliability without causing permanent lamin





























